NYTech
Companies
Companybiotech ai

Ordaos Bio

Ordaōs is a human-enabled, machine-driven drug design company. Our miniPRO™ proteins help drug hunters deliver treatments that are safer and more effective than traditional discovery methods.[1][2]

Visit website Suggest an update
2019 Founded

Overview

Ordaōs is a human-enabled, machine-driven drug design company [2] headquartered at 101 Avenue of the Americas in New York [7]. The company creates de novo mini-proteins to help drug hunters deliver life-saving treatments [5], with its miniPRO™ proteins designed to deliver treatments that are safer and more effective than traditional discovery methods [2]. As of the available data, Ordaōs operates with 24 employees [4] and is categorized within biotechnology research [3]. The company is listed among New York AI companies [1] and maintains a LinkedIn presence with 5,107 followers [6].

Business address: 101 Avenue of the Americas, New York, New York, 10013. [7]

Growth & traction

LinkedIn lists 24 people working at Ordaos Bio. [4]

Focus

  • Ordaos Bio describes itself as "Ordaōs creates de novo mini-proteins to help drug hunters deliver life-saving treatments.".[5]

Something wrong or missing? Send an update. Fixed within 24 hours.